NWPF

News ArchivesRead News

Researchers identify chemical signature for 'fast' form of Parkinson's

Monday November 25, 2013

The detection of this biomarker could help in early detection of the degenerative disorder, helping doctors plan out a course of treatment to manage the incurable disease.
Ananth Baliga

UPI - Scientists at UCLA and Emory University have identified a biochemical signature in the blood of patients with the faster-progressing form of Parkinson's disease.

Researchers conducted the study using blood samples from 250 Parkinson's patients in the early stages of the disease. Forty were identified as having the slower-progressing Parkinson's and 40 had the faster-progressing form of the degenerative disease.

On comparing the blood samples of these individuals with samples of 20 healthy individuals, they found a potential biomarker called N8-acetyl spermidine, which was significantly elevated in the fast-progressors.

"Such biomarkers reflecting the pathogenesis of Parkinson's are greatly needed due to the fact that the degeneration of the neurons in the brain that produce dopamine -- a hallmark of Parkinson's disease -- is an irreversible process. In addition, that process begins up to 20 to 30 years before imaging can identify any brain changes," said Beate Ritz, a professor at UCLA.

Researchers say the discovery of this biomarker could help in early detection and more effective disease management. Their findings are published online in PLOS ONE.

Parkinson's is a degenerative disorder of the central nervous system. It initially manifests as movement-related problems like shaking, rigidity and slowness of movement, progressing to thinking and behavioral problems later on.

You can read the full scientific journal article at http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0077629

Baliga, A. (25 Nov. 2013). UPI. Researchers identify chemical signature for 'fast' form of Parkinson's. www.upi.com.

Recent News

Oct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 18 - Fighting Parkinson's disease through dance
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show